Third generation oral contraceptives: Caution is still justified

作者: D. C G Skegg

DOI: 10.1136/BMJ.321.7255.190

关键词:

摘要: Oral contraception is effective, convenient, and reversible. For most women it also remarkably safe. Some people involved in family planning go further imply that the oral contraceptive pill almost free of risk. This creates an illusion shattered whenever adverse effects—however rare—are brought to light. In October 1995 Committee on Safety Medicines United Kingdom warned contraceptives containing desogestrel or gestodene carried a small increase risk venous thromboembolism compared with older preparations. The chaos followed Britain (and few other countries) may have stemmed partly from absolute safety, as well publicity triggered by warning. The committee's announcement was publication four designed studies gave consistent picture: using third generation had about twice preparations levonorgestrel.1 years followed, plethora articles, reviews, symposiums implied these reports were flawed reanalyses new show no differences …

参考文章(14)
Vandenbroucke Jp, Rosendaal Fr, Helmerhorst Fm, Competing interests and controversy about third generation oral contraceptives. BMJ. ,vol. 320, ,(2000)
Samy Suissa, Lucie Blais, Walter O. Spitzer, Jean Cusson, Michael Lewis, Lothar Heinemann, First-time use of newer oral contraceptives and the risk of venous thromboembolism Contraception. ,vol. 56, pp. 141- 146 ,(1997) , 10.1016/S0010-7824(97)00119-4
Catherine Vasilakis, Hershel Jick, Maria del Mar Melero-Montes, Risk of idiopathic venous thromboembolism in users of progestagens alone. The Lancet. ,vol. 354, pp. 1610- 1611 ,(1999) , 10.1016/S0140-6736(99)04394-9
Alexander M Walker, Newer oral contraceptives and the risk of venous thromboembolism. Contraception. ,vol. 57, pp. 169- 181 ,(1998) , 10.1016/S0010-7824(98)00014-6
Catherine Vasilakis, Susan S Jick, Hershel Jick, The risk of venous thromboembolism in users of postcoital contraceptive pills. Contraception. ,vol. 59, pp. 79- 83 ,(1999) , 10.1016/S0010-7824(99)00011-6
Jan Rosing, Saskia Middeldorp, Joyce Curvers, M Christella L GDlig; Thomassen, Gerry AF Nicolaes, Joost CM Meijers, Bonno N Bouma, Harry R Büller, Martin H Prins, Guido Tans, Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study. The Lancet. ,vol. 354, pp. 2036- 2040 ,(1999) , 10.1016/S0140-6736(99)06092-4
Michael A. Lewis, Kenneth D. MacRae, Dörthe Kühl-Habich1, Rudolf Bruppacher, Lothar A.J. Heinemann, Walter O. Spitzer*, The differential risk of oral contraceptives: the impact of full exposure history* Human Reproduction. ,vol. 14, pp. 1493- 1499 ,(1999) , 10.1093/HUMREP/14.6.1493